ASML Research Update — August 28, 2026 (Updated)
Updated Thesis
ASML Holding N.V. is the dominant supplier of lithography systems, including extreme ultraviolet (EUV) and deep ultraviolet (DUV) systems, essential for manufacturing advanced semiconductors. The company enjoys a near-monopoly in EUV with no comparable competition, supported by high barriers to entry and a strong moat.
The investment grade as of this refresh is C — average business quality. High-tier business, very expensive valuation with 0.6% upside to fair value.
Key Metrics at a Glance
- Revenue growth: +21.3% year over year
- Net margin: 30.1%
- Fair value upside: +0.6% to our estimate of $1725
Current price: $1714.88
These figures reflect our most recent data pull and are one input into a multi-factor valuation framework.
Our 12–18 Month Outlook
Quality companies held over a multi-year horizon benefit from compounding fundamentals and the patience to ride through short-term volatility. ASML Holding N.V. remains in our covered universe with a average-quality assessment. We update research when material data changes — earnings revisions, management shifts, or regime changes in valuation — not on every price fluctuation.
Long-term accumulation of quality businesses at fair or better prices is the core of the Patient Accumulator approach. Research updates like this one inform whether to add, hold, or wait for a better zone — not whether to react to short-term price moves.
[View full ASML research →](/stocks/ASML)